ライフサイエンスコーパス: considerations for

1 rectomy on living donors have been important considerations for 60 years.

2 ly and late sustained VT/VF raises important considerations for aggressive monitoring beyond 48 hours

3 rences among these methods lead to important considerations for all steps of genomics studies, from t

4 Special considerations for allelic inclusion are treated in the

5 om other ambulatory practices and has unique considerations for an effective administrative structure

6 To evaluate design considerations for an osteoporosis large simple trial (L

7 s; 9) treatment for acute HIV infection; 10) considerations for antiretroviral therapy among adolesce

8 ntiretroviral therapy among adolescents; 11) considerations for antiretroviral therapy among pregnant

9 enefit ratio and safety issues are important considerations for any new emerging therapies.

10 Implications for risk assessment and considerations for application of multi-ratio equilibriu

11 with acetals is introduced, and mechanistic considerations for both MAP methods are described.

12 ging as redox-active proteins require design considerations for both the reduced and oxidized states

13 therapeutic outcomes are, however, important considerations for both treatment options.

14 ought to underlie hunger in order to outline considerations for bridging the gap between homeostatic

15 Considerations for cardiac imaging in pregnancy are also

16 are addressed in addition to the many other considerations for caring for this group of complex pati

17 Here, we review the major considerations for carrying out and interpreting results

18 egulatory mechanisms for CART and additional considerations for CART's role in brain.

19 atch effects and genomic waves are important considerations for case-parent studies of de novo CNV, a

20 verse events; 7) interruption of therapy; 8) considerations for changing therapy and available therap

21 f peritoneal membrane function are important considerations for children on long term dialysis.

22 ghts these differences and discusses special considerations for cholesterol management in the adolesc

23 ring and distribution processes are critical considerations for clinical application that should be c

24 linical practice has highlighted interesting considerations for clinical trial design and opened up o

25 e explore potential hypotheses and important considerations for clinical trial designs.

26 Considerations for clinical trials of restorative therap

27 orders among adolescents, highlights general considerations for co-occurring disorders treatment, rev

28 herapeutic discovery and provide theoretical considerations for combining orthogonal cancer therapies

29 Four components (3-6) are assembled with considerations for control of absolute and relative ster

30 de by outlining some of the important design considerations for controlling particle shape as learned

31 arize this work by proposing a set of design considerations for controlling the growth and final shap

32 with other assessments, to discuss personnel considerations for CPX laboratories, and to provide reco

33 methodologies used across other fields, key considerations for data integration models in congenital

34 level technologies, and discuss some general considerations for deploying mass cytometry in the conte

35 by discussing some of the related pragmatic considerations for deploying the first generation of a '

36 techniques and the influence of nutritional considerations for diabetes management are also discusse

37 he extracellular matrix, describe the design considerations for different tissues and discuss the imp

38 See the Clinical Considerations for discussion of adequacy of prior scree

39 See the Clinical Considerations for discussion of cytology method, HPV te

40 in African Americans and to highlight unique considerations for disease prevention and management.

41 Among the most important considerations for donation after circulatory death (DCD

42 Design considerations for each of these experimental approaches

43 fects of siRNA molecules, and the key design considerations for effective delivery systems has spurre

44 Important considerations for effective treatment include careful p

45 emphasizing the philosophical and practical considerations for effectively merging these two types o

46 This review highlights important considerations for engineering the microenvironment for

47 pe and duration of the disease-two important considerations for envisioned therapeutic interventions.

48 This article discusses methodological considerations for equity-oriented monitoring of UHC, an

49 In this report, we suggest methodological considerations for ESR as pertains to magnetism, sample

50 gs of transdifferentiation, disease-specific considerations for establishing a therapeutically effect

51 Clinical considerations for evidence-based treatment of borderlin

52 rimotor transformations, outlining important considerations for experimental design and considering h

53 In addition, strategic considerations for experimental design and variables wil

54 e protocol describes all steps, ranging from considerations for experimental design, Co-IP, preparati

55 method and discuss theoretical and technical considerations for experimental design.

56 Theoretical considerations for extending the application of quantita

57 sue of coverage, as well as their underlying considerations, for four major study designs, which incl

58 Considerations for future directions in gambling researc

59 ies in management, prognostic variables, and considerations for future directions.

60 Important considerations for future research as well as potential

61 Considerations for future research to complement imaging

62 ptualization and measurement raise important considerations for future studies attempting to identify

63 line potential methodological and conceptual considerations for future studies of lncRNAs in the hear

64 ex human diseases, suggest several important considerations for future studies.

65 iew clinical, policy, safety, and regulatory considerations for generic oncology drugs focusing on th

66 Finally, we reiterate important considerations for goal research moving forward.

67 retargeted radioimmunotherapy, and important considerations for harnessing the pretargeting strategy

68 together with a consensus reached on safety considerations for healthy blood stem cell donors.

69 ine and improve their specificities, and key considerations for how to evaluate and reduce off-target

70 of modern live cell imaging and the special considerations for imaging live plant specimens.

71 radiologists to be familiar with the unique considerations for imaging women with heart disease.

72 Clinical considerations for implantable bioprinted tissues are fu

73 Among several important considerations for implantation of a biomaterial, a main

74 s applications in clinical microbiology, and considerations for implementation of the method in a cli

75 cal foundations of our framework and discuss considerations for implementing its various components.

76 Lastly, some potential considerations for improvement in this field are also di

77 t-effectiveness analysis, but also on safety considerations for individual agents.

78 ical limit of helicity emerges from helicity considerations for individual superfluid vortex filament

79 In this review, we discuss treatment considerations for infections caused by extended-spectru

80 In addition, expectations and considerations for information to be included in the man

81 We argue that the risk-benefit considerations for initiating ART are not the same world

82 This review aims to highlight the strategic considerations for introduction of the cyclopropane moti

83 r prognosis, mtDNA as cancer biomarkers, and considerations for investigating the role of mtDNA in ca

84 allenges of genomic footprinting, as well as considerations for its application to complex genomes.

85 ination status and to explore methodological considerations for linked survey implementation.

86 We addressed these considerations for male tree lizards (Urosaurus ornatus)

87 Considerations for management include prophylactic IOP-l

88 th maternal and fetal disorders, and special considerations for management make it essential for obst

89 bes these alterations and provides practical considerations for management of medications.

90 l utility and consumer appeal need to be key considerations for measures intended to be used in every

91 These are important considerations for modeling future biosphere-atmosphere

92 c health laboratory setting, and it includes considerations for NGS test validation, quality control

93 nges to nasal delivery, and drug/formulation considerations for nose to brain delivery are also discu

94 Special considerations for nutrition; medication use; cardiovasc

95 medications studied for obesity and provide considerations for obesity medication use in clinical pr

96 eneral experimental strategies and practical considerations for obtaining kinetic data of sufficient

97 We have examined these considerations for open pond systems, to identify variab

98 eir statistical properties are examined, and considerations for optimal experimental design are discu

99 Additionally, considerations for optimization of the DESI-MS process a

100 Quality control methods and considerations for optimizing flow conditions are detail

101 Design considerations for optimizing these devices for liquid-p

102 treatment of neurogenic pulmonary edema, and considerations for organ donation.

103 Similar general considerations for out-of-operating room anesthesia equa

104 l be discussed with a particular emphasis on considerations for parents of teenagers.

105 These recent studies highlight important considerations for patient selection, SWL technique and

106 A framework of key considerations for patients with active brain metastases

107 artment syndrome (MCS) and current treatment considerations for patients with TBI given the effects o

108 ested when using the data to guide treatment considerations for patients.

109 work and describe theoretical and practical considerations for performing and interpreting SeqChIP e

110 d, this protocol includes itemized steps and considerations for performing immunocytochemistry, acqui

111 insecticide timing and efficacy are crucial considerations for pest management.

112 lur personal and work identities, posing new considerations for physician professionalism in the info

113 over, these findings suggest new therapeutic considerations for PI3K and/or AKT inhibitors for cancer

114 rs revisit the topic and highlight important considerations for policy-makers related to the impact o

115 ts across socioeconomic groups are important considerations for policy-makers.

116 A literature review was performed and considerations for pragmatic management were proposed.

117 competitive athletes importantly influences considerations for pre-participation screening strategie

118 We discuss methodological and practical considerations for preclinical modeling of additive/syne

119 hlighting anesthetic, obstetric and surgical considerations for pregnant trauma victims was performed

120 We also offer pathophysiological considerations for primary TCH.

121 n native human proteins we explore potential considerations for producing a specification for misinco

122 and articulated important equity and ethical considerations for protecting the health and safety of l

123 dual sensory impairment, with an emphasis on considerations for provision of appropriate hearing assi

124 These are important considerations for quantitative studies in animal models

125 ant new paradigm of cancer treatment and key considerations for rational design of nanomedicine of sy

126 n genomic data sets and highlights important considerations for research communities that are develop

127 These recent findings have important considerations for research, vaccine development, and cl

128 Our results underscore two general considerations for researchers proposing novel types of

129 s the state of the science of CTE and raises considerations for researching and interpreting cognitiv

130 General mechanistic considerations for RNA catalysis suggest that the penalt

131 n this study, fundamental differences in the considerations for RNA interference and antisense ODNs a

132 yses, as well as including potential quality considerations for safe and reliable transportation and

133 We describe special considerations for sample preparation and digestion, mas

134 We propose a few considerations for scholars interested in joining the ev

135 We discuss considerations for screen design, and we present complet

136 our protocol offers a set of suggestions and considerations for screen optimization and a step-by-ste

137 management of these complications as well as considerations for sedation, analgesia, anticoagulation,

138 areas: advances in ALK testing methodology, considerations for selecting appropriate populations for

139 This case offers new potential considerations for short- and long-term management of no

140 approach combines some of the most important considerations for species vulnerability in a straightfo

141 ensive list of recommendations that includes considerations for specific populations is also provided

142 We also provide technical considerations for standardization and further improveme

143 with an accompanying description of possible considerations for study design.

144 pharmacogenomics with a focus on the special considerations for study design.

145 nd are used to highlight some of the primary considerations for studying misfolded proteins associate

146 e, and function and will highlight technical considerations for studying this population.

147 rapeutic implications, and discuss practical considerations for successful application of tumor genot

148 We present several considerations for such a reduction in data collection,

149 Design considerations for such a trial should include the need

150 Putative design strategies and experimental considerations for such probes are discussed.

151 we describe theoretical and empirical design considerations for such sequencing studies, aimed at max

152 We outline some practical considerations for such simulations.

153 ominic Kwiatkowski discuss important ethical considerations for sustainable genomics research in Afri

154 lational treatments are discussed, including considerations for targeted inhibition of VEGF signaling

155 ases as well as highlighting a wide range of considerations for the analysis of transcriptomic data.

156 Considerations for the anesthetic management of patients

157 Second, we elaborate on economic considerations for the application of antiadhesion barri

158 ted coronary artery disease, with additional considerations for the application of the test in specif

159 We also raise important considerations for the assessment and evaluation of such

160 e spectral range, whereas the phase-matching considerations for the Brillouin process require optical

161 e will provide an overview of the regulatory considerations for the clinical development and licensur

162 In this review, we discuss important considerations for the design and interpretation of clus

163 These findings highlight important considerations for the design and testing of candidate H

164 RNA by viral RdRPs, thus providing important considerations for the design of improved mutagenic anti

165 -analysis was used to examine relative power considerations for the design of phase II and phase III

166 In this article, I discuss considerations for the design of such a trial in a regio

167 These factors are important considerations for the design of vancomycin analogues to

168 of cRCTs and highlight and explain important considerations for the design, analysis, and reporting o

169 ive prevention of metachronous CRC, specific considerations for the detection of local recurrence in

170 One of the important considerations for the development of on-chip batteries

171 These findings raise important considerations for the development of peptide therapies

172 ons under positive selection, both important considerations for the development of vaccines and T-cel

173 umoral cross-reactivity and discuss relevant considerations for the development of vaccines and thera

174 These are useful considerations for the formulation of treatment policy (

175 Furthermore, primer design considerations for the G-quadruplex-generating PCR syste

176 enefits of routine vaccination are important considerations for the inclusion of Dengvaxia into exist

177 domen was performed to narrow the diagnostic considerations for the lesions identified at CT.

178 argeted temperature management and practical considerations for the management of medications.

179 These results pose critical considerations for the methods used to design and evalua

180 Scaling considerations for the modern practice of combination ch

181 toxicity and biocompatibility were important considerations for the new bioactive materials.

182 ensus recommendations and medical management considerations for the patient newly diagnosed with a le

183 trategies, and comment on present and future considerations for the regulatory review of diabetes dru

184 We also highlight practical considerations for the selection of climate models and d

185 tual, practical, statistical, and logistical considerations for the use of microarrays in studies of

186 These data raise important considerations for the use of specific immunotherapies i

187 panded criteria donor organ utilization, and considerations for the way forward are discussed.

188 that elite athletes should receive the same considerations for their airway health as others with po

189 ents and engineering poxviruses with special considerations for their effect on M2 macrophage-contain

190 rs to clinical translation of MNPs and offer considerations for their future development.

191 se co-occurring compounds suggests important considerations for their respective biodegradation proce

192 ill review ebolavirus vaccine candidates and considerations for their use in humans and wild apes.

193 ments in these methods and discuss practical considerations for their use in imaging proteins inside

194 both IL-6 and IL-17 functions are important considerations for therapies of chronic viral diseases,

195 ; 4) adherence to antiretroviral therapy; 5) considerations for therapy among patients with advanced

196 re, and myocarditis), and explore management considerations for these groups, with particular emphasi

197 Here we discuss technical considerations for these high-throughput assays, togethe

198 Experts might review safety considerations for these laboratory testing/diagnostic a

199 ntaneous hyphaema and adds to the management considerations for this condition.

200 ment of such masses and comment on technical considerations for this particular ablative technique.

201 pathogenesis, and diagnostic and therapeutic considerations for this previously unrecognized disease.

202 Anesthetic considerations for thoracic and thoracoscopic neurosurgi

203 We also outline the important considerations for those referencing identifiers in vari

204 after total pancreatectomy; and (5) registry considerations for TPIAT.

205 lly, we provide an overview of the treatment considerations for treating migraine with psychiatric co

206 and B cells in IPF pathogenesis, and support considerations for trials of specific B-cell-targeted th

207 in non-hematopoietic cells are important new considerations for understanding AhR-mediated changes in

208 form oligonucleotide are potentially general considerations for understanding DNA-binding affinity an

209 a was conducted, with particular emphasis on considerations for urologic referral.

210 Finally, we discuss considerations for using alternative indicators for wate

211 We also discuss special considerations for using IAD outside the context of a cl

212 Critical considerations for using isotopically labeled rhGH as th

213 Molecular and clinical considerations for using neoadjuvant chemotherapy in the

214 Part 2 discusses more fully the ethical considerations for using placebo controls in particular

215 This new understanding raises important considerations for vaccine design and for the measuremen

216 Special considerations for video-assisted thoracoscopic surgery,

217 Our results provide important considerations for viral vectors to be used in future ge

218 sting for antiretroviral drug resistance; 3) considerations for when to initiate therapy; 4) adherenc

219 We present practical handling and safety considerations for working with this reactive biomolecul